Oxali-Bendalis (Oxaliplatin)

Oxaliplatin, the active ingredient in Oxali-Bendalis, is a platinum-based chemotherapy presented as a injection for intravenous use. It treats colorectal cancer and other gastrointestinal malignancies in adult patients. GNH USA supplies Oxali-Bendalis as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxali-Bendalis as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Oxali-Bendalis acts on the DNA repair pathway of cancer cells and is used for the following clinical conditions: - Col  ​   .... - ...  ....  ...

{"...":"..."}